IGC Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
CEORam Mukunda
CEORam Mukunda
Employees70
Employees70
HeadquartersPotomac, Maryland
HeadquartersPotomac, Maryland
Founded2005
Founded2005
Employees70
Employees70
IGC Key Statistics
Market cap37.16M
Market cap37.16M
Price-Earnings ratio-5.15
Price-Earnings ratio-5.15
Dividend yield—
Dividend yield—
Average volume800.45K
Average volume800.45K
High today$0.46
High today$0.46
Low today$0.4002
Low today$0.4002
Open price$0.4162
Open price$0.4162
Volume789.37K
Volume789.37K
52 Week high$0.4985
52 Week high$0.4985
52 Week low$0.2525
52 Week low$0.2525
IGC News
TipRanks 3d
IGC Pharma expands Phase 2 CALMA trial to University of South FloridaIGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial evaluating investigational drug candidate IGC-AD1 for agitation in Alzheime...
People also own
Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.